安捷凯在线客服
- 客服:
- 电话: 13061953619
- 微信:
PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
PRN1008 (Rilzabrutinib) is a reversible covalent, selective and oral active inhibitor of Bruton’s Tyrosine Kinase (BTK), with an IC50 of 1.3 nM.
[1] Smith PF, et al. 2017 Nov;83(11):2367-2376.
动态评分
0.0